Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.8680
+0.0055 (0.64%)
May 2, 2025, 9:51 AM EDT - Market open
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $77.86 million as of May 2, 2025. Its market cap has increased by 225.12% in one year.
Market Cap
77.86M
Enterprise Value
-16.84M
1-Year Change
225.12%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $77.86M, an increase of 52.59%. That is a compound annual growth rate of 12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 77.77M | -17.43% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 727.17B |
| Johnson & Johnson | 373.81B |
| UnitedHealth Group | 361.50B |
| AbbVie | 347.41B |
| Novo Nordisk | 298.09B |
| Abbott Laboratories | 230.22B |
| Novartis AG | 223.05B |
| AstraZeneca | 218.59B |